VITRAKVI

Medicinal product

(Invented) name

VITRAKVI

Active substance (s)

Larotrektinibas

Strength

25 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01EX12, Larotrectinib

Marketing authorisation holder

Bayer AG, Vokietija

Date of authorisation

2019-09-19

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Hard capsule	1 vnt.
Larotrektinibas	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
102395	88495	1088495	buteliukas	N56		Receptinis	EU/1/19/1385/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2019-09-19	Registruotas